top of page
India ranks second in global cancer mortality
Very high number of patients relapse and/or refractory to conventional therapies: Leukaemia and Lymphoma*
High response rate: CAR-T cells are highly effective compared to chemotherapy, biologics and bone marrow transplant
* Based on inputs from multiple centres in India
Difference Between Cancer and normal cells
What is Cancer?
How Does Cancer Develop?
Type of Cancers
CAR-T : The Intent to Cure Cancer
Recoveries are the strongest motivation
Journey of these patients, who, with the unwavering support of their families, fastidious and keen treatment-care by provided by Tata Memorial Hospital, and the cutting-edge treatment of ImmunoACT’s Actaly-cel, have emerged victorious in their battle against cancer.
They are now in remission, and in pursuit of better clinical outcomes. Their stories serve as a beacon of hope and a testament to the power of perseverance, love, and advanced medical treatment.
bottom of page